BAGNASCO, DIEGO
BAGNASCO, DIEGO
100007 - Dipartimento di Medicina interna e specialità mediche
30 Years Of Sublingual Immunotherapy
2019-01-01 Passalacqua, Giovanni; Bagnasco, Diego; Canonica, Giorgio Walter
A case of chronic eosinophilic pneumonia in a patient treated with dupilumab
2019-01-01 Menzella, F.; Montanari, G.; Patricelli, G.; Cavazza, A.; Galeone, C.; Ruggiero, P.; Bagnasco, D.; Facciolongo, N.
A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma
2016-01-01 Bagnasco, Diego; Ferrando, Matteo; Varricchi, Gilda; Passalacqua, Giovanni; Canonica, Giorgio
Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study
2020-01-01 Caruso, C.; Brame, B.; Bagnasco, D.; Cocconcelli, A.; Ortolani, V.; Pravettoni, V.; Scarpa, S.; Zisa, G.; Passalacqua, G.; Colantuono, S.
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life
2019-01-01 Lombardi, Carlo; Bagnasco, Diego; Caruso, Cristiano; D'Amato, Mariella; Menzella, Francesco; Milanese, Manlio; Senna, Gianenrico; Canonica, Giorgio Walter; Passalacqua, Giovanni
Anti-IL-5 and IL-5Ra: Efficacy and safety of new therapeutic strategies in severe uncontrolled asthma
2018-01-01 Bagnasco, Diego; Caminati, Marco; Ferrando, Matteo; Aloè, Teresita; Testino, Elisa; Canonica, Giorgio Walter; Passalacqua, Giovanni
Anti-il5 therapies for severe eosinophilic asthma: Literature review and practical insights
2020-01-01 Menzella, F.; Ruggiero, P.; Ghidoni, G.; Fontana, M.; Bagnasco, D.; Livrieri, F.; Scelfo, C.; Facciolongo, N.
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
2017-01-01 Bagnasco, Diego; Ferrando, Matteo; Varricchi, Gilda; Puggioni, Francesca; Passalacqua, Giovanni; Canonica, Giorgio Walter
Application of bioendoscopy filters in endoscopic assessment of sinonasal Schneiderian papillomas
2021-01-01 Carobbio, A. L. C.; Vallin, A; Ioppi, A; Missale, F; Ascoli, A; Mocellin, D; Bagnasco, D; Mora, R; Peretti, G; Canevari, F. R. M.
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
2021-01-01 Lombardi, C.; Asero, R.; Bagnasco, D.; Blasi, F.; Bonini, M.; Bussi, M.; Canevari, F. R. M.; Canonica, G. W.; Castelnuovo, P.; Cecchi, L.; Cosmi, L.; Gelardi, M.; Heffler, E.; Indinnimeo, L.; Landi, M.; Licari, A.; Liotta, F.; Macchi, A.; Malvezzi, L.; Marseglia, G.; Micheletto, C.; Musarra, A.; Peroni, D.; Piacentini, G.; Poletti, V.; Richeldi, L.; Santoni, A.; Schiappoli, M.; Senna, G.; Vaghi, A.; Villani, A.; Passalacqua, G.
Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report
2021-01-01 Solidoro, P.; Nicola, S.; Ridolfi, I.; Bucca, C.; Heffler, E.; Bagnasco, D.; Canonica, G. W.; Blasi, F.; Paggiaro, P.; Rolla, G.; Brussino, L.
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
2021-01-01 Caminati, M.; Vultaggio, A.; Matucci, A.; Senna, G.; Almerigogna, F.; Bagnasco, D.; Chieco-Bianchi, F.; Cosini, F.; Girelli, D.; Guarnieri, G.; Menzella, F.; Micheletto, C.; Olivieri, O.; Passalacqua, G.; Pini, L.; Rossi, O.; Vianello, A.; Vivarelli, E.; Crisafulli, E.
Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma
2016-01-01 Passalacqua, Giovanni; Canonica, Giorgio; Bagnasco, Diego
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
2023-01-01 Caminati, Marco; Marcon, Alessandro; Guarnieri, Gabriella; Miotti, Jessica; Bagnasco, Diego; Carpagnano, Giovanna Elisiana; Pelaia, Girolamo; Vaia, Rachele; Maule, Matteo; Vianello, Andrea; Senna, Gianenrico
Biological agents for severe asthma: the evolution of the at-home self-injection approach.
2020-01-01 Lombardi, C; Bagnasco, D; Passalacqua, G
Biologicals for severe asthma: what we can learn from real-life experiences?
2020-01-01 Bagnasco, Diego; Caminati, Marco; Passalacqua, Giovanni
Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study
2020-01-01 Menzella, F; Galeone, C; Ruggiero, P; Bagnasco, D; Catellani, C; Facciolongo, N.
Biologics for the Treatments of Allergic Conditions: Severe Asthma
2020-01-01 Caminati, M; Bagnasco, D; Rosenwasser, Lj; Vianello, A; Senna, G.
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
2022-01-01 Solidoro, P.; Nicola, S.; Ridolfi, I.; Canonica, G. W.; Blasi, F.; Paggiaro, P.; Heffler, E.; Bagnasco, D.; Patrucco, F.; Ribolla, F.; Bucca, C.; Rolla, G.; Albera, C.; Brussino, L.
Biosimilars in allergic diseases
2016-01-01 Ferrando, Matteo; Bagnasco, Diego; Braido, Fulvio; Varricchi, Gilda; Canonica, Giorgio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 30 Years Of Sublingual Immunotherapy | 1-gen-2019 | Passalacqua, Giovanni; Bagnasco, Diego; Canonica, Giorgio Walter | |
| A case of chronic eosinophilic pneumonia in a patient treated with dupilumab | 1-gen-2019 | Menzella, F.; Montanari, G.; Patricelli, G.; Cavazza, A.; Galeone, C.; Ruggiero, P.; Bagnasco, D.; Facciolongo, N. | |
| A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma | 1-gen-2016 | Bagnasco, Diego; Ferrando, Matteo; Varricchi, Gilda; Passalacqua, Giovanni; Canonica, Giorgio | |
| Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study | 1-gen-2020 | Caruso, C.; Brame, B.; Bagnasco, D.; Cocconcelli, A.; Ortolani, V.; Pravettoni, V.; Scarpa, S.; Zisa, G.; Passalacqua, G.; Colantuono, S. | |
| Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life | 1-gen-2019 | Lombardi, Carlo; Bagnasco, Diego; Caruso, Cristiano; D'Amato, Mariella; Menzella, Francesco; Milanese, Manlio; Senna, Gianenrico; Canonica, Giorgio Walter; Passalacqua, Giovanni | |
| Anti-IL-5 and IL-5Ra: Efficacy and safety of new therapeutic strategies in severe uncontrolled asthma | 1-gen-2018 | Bagnasco, Diego; Caminati, Marco; Ferrando, Matteo; Aloè, Teresita; Testino, Elisa; Canonica, Giorgio Walter; Passalacqua, Giovanni | |
| Anti-il5 therapies for severe eosinophilic asthma: Literature review and practical insights | 1-gen-2020 | Menzella, F.; Ruggiero, P.; Ghidoni, G.; Fontana, M.; Bagnasco, D.; Livrieri, F.; Scelfo, C.; Facciolongo, N. | |
| Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma | 1-gen-2017 | Bagnasco, Diego; Ferrando, Matteo; Varricchi, Gilda; Puggioni, Francesca; Passalacqua, Giovanni; Canonica, Giorgio Walter | |
| Application of bioendoscopy filters in endoscopic assessment of sinonasal Schneiderian papillomas | 1-gen-2021 | Carobbio, A. L. C.; Vallin, A; Ioppi, A; Missale, F; Ascoli, A; Mocellin, D; Bagnasco, D; Mora, R; Peretti, G; Canevari, F. R. M. | |
| ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments | 1-gen-2021 | Lombardi, C.; Asero, R.; Bagnasco, D.; Blasi, F.; Bonini, M.; Bussi, M.; Canevari, F. R. M.; Canonica, G. W.; Castelnuovo, P.; Cecchi, L.; Cosmi, L.; Gelardi, M.; Heffler, E.; Indinnimeo, L.; Landi, M.; Licari, A.; Liotta, F.; Macchi, A.; Malvezzi, L.; Marseglia, G.; Micheletto, C.; Musarra, A.; Peroni, D.; Piacentini, G.; Poletti, V.; Richeldi, L.; Santoni, A.; Schiappoli, M.; Senna, G.; Vaghi, A.; Villani, A.; Passalacqua, G. | |
| Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report | 1-gen-2021 | Solidoro, P.; Nicola, S.; Ridolfi, I.; Bucca, C.; Heffler, E.; Bagnasco, D.; Canonica, G. W.; Blasi, F.; Paggiaro, P.; Rolla, G.; Brussino, L. | |
| Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity | 1-gen-2021 | Caminati, M.; Vultaggio, A.; Matucci, A.; Senna, G.; Almerigogna, F.; Bagnasco, D.; Chieco-Bianchi, F.; Cosini, F.; Girelli, D.; Guarnieri, G.; Menzella, F.; Micheletto, C.; Olivieri, O.; Passalacqua, G.; Pini, L.; Rossi, O.; Vianello, A.; Vivarelli, E.; Crisafulli, E. | |
| Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma | 1-gen-2016 | Passalacqua, Giovanni; Canonica, Giorgio; Bagnasco, Diego | |
| Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective | 1-gen-2023 | Caminati, Marco; Marcon, Alessandro; Guarnieri, Gabriella; Miotti, Jessica; Bagnasco, Diego; Carpagnano, Giovanna Elisiana; Pelaia, Girolamo; Vaia, Rachele; Maule, Matteo; Vianello, Andrea; Senna, Gianenrico | |
| Biological agents for severe asthma: the evolution of the at-home self-injection approach. | 1-gen-2020 | Lombardi, C; Bagnasco, D; Passalacqua, G | |
| Biologicals for severe asthma: what we can learn from real-life experiences? | 1-gen-2020 | Bagnasco, Diego; Caminati, Marco; Passalacqua, Giovanni | |
| Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study | 1-gen-2020 | Menzella, F; Galeone, C; Ruggiero, P; Bagnasco, D; Catellani, C; Facciolongo, N. | |
| Biologics for the Treatments of Allergic Conditions: Severe Asthma | 1-gen-2020 | Caminati, M; Bagnasco, D; Rosenwasser, Lj; Vianello, A; Senna, G. | |
| Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center | 1-gen-2022 | Solidoro, P.; Nicola, S.; Ridolfi, I.; Canonica, G. W.; Blasi, F.; Paggiaro, P.; Heffler, E.; Bagnasco, D.; Patrucco, F.; Ribolla, F.; Bucca, C.; Rolla, G.; Albera, C.; Brussino, L. | |
| Biosimilars in allergic diseases | 1-gen-2016 | Ferrando, Matteo; Bagnasco, Diego; Braido, Fulvio; Varricchi, Gilda; Canonica, Giorgio |